Lataa...
Clinical utility of eslicarbazepine: current evidence
Eslicarbazepine acetate (ESL) is a new antiepileptic drug whose mechanism of action is blockade of the voltage-gated sodium channel (VGSC). However, in respect to carbamazepine and oxcarbazepine, the active ESL metabolite (eslicarbazepine) affects slow inactivation of VGSC and has a similar affinity...
Tallennettuna:
| Julkaisussa: | Drug Des Devel Ther |
|---|---|
| Päätekijät: | , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Dove Medical Press
2015
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4330027/ https://ncbi.nlm.nih.gov/pubmed/25709402 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S57409 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|